Safety and Efficacy of Chlorthalidone in Type 1 Diabetes
Status:
Terminated
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
This open-label study will determine if chlorthalidone is safe and effective for the use of
reducing urinary calcium excretion over 4 weeks in subjects with type 1 diabetes
Phase:
Phase 2
Details
Lead Sponsor:
University of Rochester
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)